- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04261660
Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer
February 7, 2020 updated by: Ido Feferkorn, Carmel Medical Center
Assessing the relationship between the VEGF levels in blood and the IVF protocol
Study Overview
Detailed Description
The investigators are assessing the VEGF levels in the blood in IVF patients undergoing different protocols
Study Type
Observational
Enrollment (Anticipated)
90
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: ido Fefekorn, MD
- Phone Number: +972-54-3537401
- Email: idofe@clalit.org.il
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Female patients undergoing ovum pickup and embryo transfer as part of assited reproductive technologies
Description
Inclusion Criteria:
Patients undergoing IVF -
Exclusion Criteria:
- Women with any malignancy
- Patients request to be withdrawn
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
fresh
NO INTERVENTION
|
NO INTERVENTION
|
Frozen embro transfer natural
NO INTERVENTION
|
NO INTERVENTION
|
Frozen embro transfer hormonal
NO INTERVENTION
|
NO INTERVENTION
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
vascular endothelial growth factor LEVELS
Time Frame: 5 days
|
levels of vascular endothelial growth factor in blood
|
5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ido Feferkorn, MD, Carmel Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2020
Primary Completion (Anticipated)
March 1, 2021
Study Completion (Anticipated)
April 1, 2021
Study Registration Dates
First Submitted
February 6, 2020
First Submitted That Met QC Criteria
February 7, 2020
First Posted (Actual)
February 10, 2020
Study Record Updates
Last Update Posted (Actual)
February 10, 2020
Last Update Submitted That Met QC Criteria
February 7, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- CMC-19-0161-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reproductive Techniques
-
National Taiwan University HospitalUnknownReproductive Techniques, Assisted | Investigative Techniques | Reproductive TechniquesTaiwan
-
Merck KGaA, Darmstadt, GermanyMerck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaboratorsCompletedAssisted Reproductive Techniques | Reproductive Technology, AssistedItaly, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece
-
Tu Du HospitalFederico II University; University of Medicine and Pharmacy at Ho Chi Minh...Recruiting
-
Royan InstituteCompletedAssisted Reproductive TechniquesIran, Islamic Republic of
-
Instituto BernabeuUnknownReproductive Techniques, AssistedSpain
-
SEID S.A.RecruitingReproductive Techniques, AssistedSpain
-
Assistance Publique Hopitaux De MarseilleUnknownAssisted Reproductive TechniquesFrance
-
Sykehuset TelemarkCompletedReproductive Techniques, AssistedNorway
-
IVI BarcelonaCompletedReproductive Techniques, AssistedSpain
-
Instituto BernabeuUnknownReproductive Techniques, AssistedSpain
Clinical Trials on NO intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States